Evidence map›Paper›PMID 7547218›Full record

ArticleBritish journal of cancer1995

Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.

L X Cubeddu, D T O'Connor, I Hoffmann, R J Parmer

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Suppression of Cisplatin-Induced Vomiting byFrontiers in pharmacology · 2018
    Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

L X CubedduDepartment of Pharmacology, School of Pharmacy, Central University of Venezuela, Caracas.
D T O'Connor
I Hoffmann
R J Parmer
Central University of Venezuela · VELos Alamos National Security (United States) · US

Funding

CHROMOGRANIN A SYNTHESIS IN HYPERTENSIONR01HL046366 · NHLBI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI O'CONNOR, DANIEL T · 1992 to 1994
–
AUTONOMIC AND RENAL PHENOTYPES IN BLACK PEDIGREESR01HL050174 · NHLBI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI PARMER, ROBERT J · 1992 to 1994
–
NHLBI NIH HHS HL-46366NHLBI NIH HHS HL-50174
6 · The paper itself

Abstract

Chromogranin A (CgA) is present in high concentrations in enterochromaffin cells, where it is co-localised with serotonin in the storage granules. Plasma CgA has been reported to mark emesis and serotonin release associated with cisplatin treatment. However, it is not known whether plasma CgA could be an indicator of emesis and of serotonin release in patients receiving non-cisplatin chemotherapies. Therefore, in this study we evaluated, in cancer patients, the temporal relationships between the increases in plasma CgA and urinary 5-hydroxyindoleacetic acid (5-HIAA) and the development of vomiting following dacarbazine, nitrogen mustard and cyclophosphamide treatments. Metoclopramide was used as antiemetic. With dacarbazine, nitrogen mustard and cyclophosphamide the median time to the onset of emesis was 2.3, 2.8 and 5.3 h and the duration of intense emesis was 3, 2 and 6 h respectively. Plasma CgA and urinary 5-HIAA increased after dacarbazine- and nitrogen mustard-based chemotherapies, with maximal increases between 4 and 6 h after initiation of drug infusion. The time course for the increases in plasma CgA paralleled that of urinary 5-HIAA and the period of intense emesis. A highly significant (P = 0.0009) positive correlation (r = 0.68) was found between the increases in plasma CgA and in urinary 5-HIAA. Cyclophosphamide treatment was not associated with increases in plasma CgA and in urinary 5-HIAA, despite inducing emesis; this indicates that the increases in CgA and 5-HIAA after dacarbazine and nitrogen mustard are not due to the act of vomiting per se. In summary, plasma CgA is a marker of serotonin release (most likely from enterochromaffin cells) after dacarbazine and nitrogen mustard-based chemotherapies, exocytosis being the most likely mechanism for the release of serotonin. Serotonin released from enterochromaffin cells seems to trigger the emetic response to dacarbazine and nitrogen mustard; however, cyclophosphamide may release serotonin from a different pool (enteric serotonin neurons and/or CNS serotonin?).

Indexed as

AdultAntineoplastic AgentsChromogranin AChromograninsCyclophosphamideDacarbazineFemaleHumansHydroxyindoleacetic AcidMaleMechlorethamineMiddle AgedSerotoninVomitingAntineoplastic AgentsCHGA protein, humanChromogranin AChromograninsCyclophosphamideDacarbazineHydroxyindoleacetic AcidMechlorethamineSerotonin

Identifiers

PMID7547218
PMCPMC2034062
OpenAlexW1964846430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.